The opinion in support of the decision being entered today was not written for publication and is not binding precedent of the Board. UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte RICHARD P. BLYE and HYUN K. KIM __________ Appeal 2007-1821 Application 11/040,964 Technology Center 1600 __________ Decided: June 1, 2007 __________ Before ERIC GRIMES, LORA M. GREEN, and RICHARD M. LEBOVITZ, Administrative Patent Judges. LEBOVITZ, Administrative Patent Judge. DECISION ON APPEAL This is a decision on appeal from the final rejection of claims 75-80 and 82-86. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. STATEMENT OF CASE The claims are drawn to a single compound, 7α,11β-dimethyl-17β- hydroxyestr-4-en-3-one 17-undecanoate. This compound is a synthetic androgen which is used as a substitute for testosterone (Specification 1: ¶¶ 4, 13). Its structure is shown in Fig. 12 of the instant disclosure.Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: September 9, 2013